MSCI Q1 2026 Earnings EPS Beats Estimates Shares Edge Higher XPON Q2 2025 Earnings Strong EPS Beat Highlights Cost Discipline ELDN Q1 2026 Earnings ClinicalStage Biotech Misses EPS Estimates Amid Ongoing Development Costs ATAI Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances DWSN Q2 2019 Earnings EPS Misses Estimates Amid Challenging Energy Market Conditions PLOW Q1 2026 Earnings Massive EPS Beat Drives Shares Higher